Comparison of montelukast and budesonide on bronchial reactivity in subjects with mild-moderate persistent asthma

We studied 51 atopic non-smoking subjects who were divided to four treatments groups: (A) montelukast 10 mg daily, (B) budesonide 400 μg twice a day (bid), (C) montelukast 10 mg daily plus budesonide 400 μg bid and (D) budesonide 800 μg bid. Bronchial responsiveness was assessed before and after 12...

Ausführliche Beschreibung